Michael Bigham's Net Worth
-$1.4 Million
Who is Michael Bigham?
Michael Bigham does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include XENOGEN CORP, SUPERNUS PHARMACEUTICALS INC, Frazier Lifesciences Acquisition Corp, Paratek Pharmaceuticals, Inc., Adamas Pharmaceuticals Inc, and CORIXA CORP.
SEC CIK
Michael Bigham's CIK is 0001216917
Past Insider Trading and Trends
2005 was Michael Bigham's most active year for acquiring shares with 10 total transactions. Michael Bigham's most active month to acquire stocks was the month of July. 2006 was Michael Bigham's most active year for disposing of shares, totalling 11 transactions. Michael Bigham's most active month to dispose stocks was the month of July. 2005 saw Michael Bigham paying a total of $4,000,001.61 for 1,786,941 shares, this is the most they've acquired in one year. In 2021 Michael Bigham cashed out on 137,894 shares for a total of $633,450.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
XENOGEN CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.12M |
—
|
—
|
0
|
Aug 9
| |||
Form 4
| +79.42% | 1.37M |
$2.91 | $4,000,001.61 | 3.11M |
Aug 11
| |||
Form 4
|
∞
| 1.73M |
—
|
—
| 1.73M |
Jul 21
| |||
Form 4
|
∞
| 5.71K |
—
|
—
| 5.71K |
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SUPERNUS PHARMACEUTICALS INC (SUPN) Snapshot price: $27.245
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 35K |
$5.29 | $189,270.00 | 35K |
Mar 20 - Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Frazier Lifesciences Acquisition Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Paratek Pharmaceuticals, Inc. No price found
Exec. Chairman the Board
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.33M |
$4.30 | $99,996.50 |
0
|
Feb 2 - Sep 21
| |||
Form 4
| +10.33% | 125K |
$2.20 | -$68,750.00 | 1.33M |
Aug 8 - Aug 9
| |||
Form 4
| +2.48% | 29.25K |
$1.99 | -$31,342.50 | 1.21M |
Scheduled
|
Dec 20 - Dec 21
| ||
Form 4
| -4.17% | -51.38K |
$1.97 | -$101,084.68 | 1.18M |
Scheduled
|
Dec 12 - Dec 13
| ||
Form 4
| -0.48% | -6.00K |
$3.47 | -$20,820.00 | 1.23M |
Scheduled
|
Oct 28
| ||
Form 4
| +2.48% | 30K |
—
|
—
| 1.24M |
Oct 25
| |||
Form 4
| +10.48% | 114.55K |
$2.66 | -$76,174.42 | 1.21M |
Scheduled
|
Aug 8 - Aug 9
| ||
Form 4
| +22.73% | 202.5K |
—
|
—
| 1.09M |
Mar 15
| |||
Form 4
| -3.42% | -31.50K |
$4.32 | -$136,126.05 | 890.78K |
Scheduled
|
Dec 13 - Dec 15
| ||
Form 4
| +4.89% | 42.97K |
$5.12 | -$163,993.60 | 922.28K |
Scheduled
|
Aug 16 - Aug 17
| ||
Form 4
| +6.23% | 51.55K |
$9.70 | -$333,330.80 | 879.31K |
Scheduled
|
May 27 - Jun 4
| ||
Form 4
| +51.46% | 281.25K |
—
|
—
| 827.77K |
Mar 30
| |||
Form 4
| -7.51% | -44.40K |
$6.81 | -$302,324.88 | 546.52K |
Scheduled
|
Dec 11 - Dec 14
| ||
Form 4
| +8.99% | 48.75K |
$5.93 | -$155,662.50 | 590.92K |
Scheduled
|
Nov 12 - Nov 13
| ||
Form 4
| -2.21% | -12.25K |
$4.68 | -$57,330.00 | 542.17K |
May 12
| |||
Form 4
| +32.19% | 135K |
—
|
—
| 554.42K |
Feb 19
| |||
Form 4
| +7.15% | 28K |
—
|
—
| 419.42K |
Oct 4
| |||
Form 4
| +44.21% | 120K |
—
|
—
| 391.42K |
Feb 26
| |||
Form 4
| +5.83% | 14.95K |
—
|
—
| 271.42K |
Jun 21 - Feb 1
| |||
Form 4
| -3.17% | -8.40K |
$6.76 | -$56,784.00 | 256.47K |
Scheduled
|
Dec 12
| ||
Form 4
| +2.99% | 7.7K |
$8.96 | -$56,448.00 | 264.87K |
Scheduled
|
Oct 12 - Oct 15
| ||
Form 4
| +45.10% | 79.94K |
$9.82 | -$160,193.66 | 257.17K |
Scheduled
|
Oct 2 - Oct 3
| ||
Form 4
| -11.27% | -22.50K |
$9.97 | -$224,325.00 | 177.23K |
Scheduled
|
Jul 2
| ||
Form 4
| -4.17% | -8.70K |
$12.70 | -$110,490.00 | 199.73K |
Scheduled
|
Apr 9
| ||
Form 4
| +11.65% | 21.75K |
—
|
—
| 208.43K |
Apr 3
| |||
Form 4
| +50.94% | 63K |
—
|
—
| 186.68K |
Feb 14
| |||
Form 4
| -3.13% | -4.00K |
$14.22 | -$56,880.00 | 123.68K |
Scheduled
|
Feb 5
| ||
Form 4
| +22.27% | 23.25K |
$4.30 | $99,996.50 | 127.68K |
Jul 19
| |||
Form 4
| +9.92% | 9.43K |
$23.58 | -$119,662.41 | 104.42K |
Scheduled
|
Jul 3 - Jul 5
| ||
Form 4
| -5.00% | -5.00K |
$15.09 | -$75,468.70 | 95K |
Scheduled
|
Feb 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| +25.00% | 20K |
$13.45 | $269,014.00 | 100K |
Jun 23
| |||
Form 4
| +60.00% | 30K |
—
|
—
| 80K |
Feb 4
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
∞
| 1.3M |
—
|
—
| 1.3M |
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adamas Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.00K |
—
|
—
|
0
|
Nov 24
| |||
Form 4
| +100.00% | 5K |
—
|
—
| 10K |
Jun 2
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||